amyloid

- The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint result consistently favored acoramidis treatment…

Martha Grogan, M.D., Cardiovascular Medicine, Mayo Clinic: Hi, I'm Dr. Martha Grogan, and I'm a cardiologist at the Mayo Clinic, and today I would like to discuss with you some information…

AMSTERDAM -- An offshoot of the closely watched A4 trial, which mainly tested whether the anti-amyloid drug…

PALO ALTO, Calif., July 14, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and…

Superior global cognition in the oldest-old was associated with resistance to…

In a study presented at the American Academy of Neurology annual meeting, researchers…

For the first time, researchers described the structure of a special type of amyloid beta plaque protein associated with Alzheimer's disease (AD) progression. In a report published May 10 in…

Kochi: India’s first centre of excellence for the evaluation and treatment of patients with suspected or established amyloidosis was…

Early brain amyloid accumulation was found in otherwise healthy young men…

There is a growing body of evidence that iron in the brain may play a role in Alzheimer's disease. Lending weight to that idea, a new imaging probe has for the first time shown that in the…